A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia (AML) (VIALE-T)

Grants and Contracts Details

StatusFinished
Effective start/end date6/10/205/12/21

Funding

  • AbbVie Incorporated: $2.00